NASDAQ:MDRX

Allscripts Healthcare Solutions Stock News

etoro logo Buy MDRX
*Your capital is at risk
$4.75
+0.250 (+5.56%)
At Close: Jun 03, 2026
WASHINGTON, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the Global Behavioral Mental Health Software Market finds that rising government funding & initiatives to encourage EHR adoption in behavioural health organizations, favourable behavioural health reforms, rising adoption of behavioural health software and huge demand for mental health services are factors that influencing the growth of Behavioral Mental Health Software Market. The total Global Behavioral Mental Health Software Market is estimated to reach USD 5.20 Billion by 2028, up from USD 2.50 Billion in 2021, at a compound annual growth rate (CAGR) of 11.1%, states Vantage Market Research, in a report, titled " Behavioral Mental Health Software Market by Component Outlook (Support Services, Software), by Delivery Model Outlook (Ownership, Subscription), by Function Outlook (Clinical, Administrative, Financial), by End-Use (Payers, Patients, Providers), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".

Digital Health Global Market Report 2022

01:32pm, Friday, 11'th Feb 2022 GlobeNewswire
Major players in the digital health market are Allscripts Healthcare Solutions Inc. , BioTelemetry Inc. , eClinicalWorks, iHealth Lab Inc, McKesson Corporation, Koninklijke Philips N. V, AT & T, Cisco Systems, Athenahealth Inc. Major players in the digital health market are Allscripts Healthcare Solutions Inc. , BioTelemetry Inc. , eClinicalWorks, iHealth Lab Inc, McKesson Corporation, Koninklijke Philips N. V, AT & T, Cisco Systems, Athenahealth Inc.
Allscripts Healthcare Solutions Inc (MDRX) shares closed today at 0.4% below its 52 week high of $21.58, giving the company a market cap of $2B. The stock is currently up 16.3% year-to-date, up 20.7% over the past 12 months, and up 79.3% over the past five years. This week, the Dow Jones Industrial Average rose 0.5%, and the S&P 500 rose 0.0%. Trading Activity Trading volume this week was 51.1% higher than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -1258.1% The company's stock price performance over the past 12 months beats the peer average by 267.2% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -111.6% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

5 Top Stocks Likely to Beat Earnings Estimates

08:28am, Thursday, 10'th Feb 2022
These top-ranked stocks are likely to beat on bottom line in their next releases.
Stocks Analysis by Zacks Investment Research covering: Henry Schein Inc, Zimmer Biomet Holdings Inc, Allscripts Healthcare Solutions Inc, Healthcare Services Group Inc. Read Zacks Investment Research''s latest article on Investing.com
Allscripts Healthcare Solutions Inc (MDRX) shares closed today at 1.3% below its 52 week high of $21.02, giving the company a market cap of $2B. The stock is currently up 12.8% year-to-date, up 23.8% over the past 12 months, and up 78.3% over the past five years. This week, the Dow Jones Industrial Average rose 4.3%, and the S&P 500 rose 5.5%. Trading Activity Trading volume this week was 61.7% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -464.8% The company's stock price performance over the past 12 months beats the peer average by 156.4% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -106.2% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Allscripts Healthcare Solutions Inc (MDRX) shares closed today at 1.0% below its 52 week high of $21.02, giving the company a market cap of $2B. The stock is currently up 9.6% year-to-date, up 22.5% over the past 12 months, and up 72.7% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 4.3%. Trading Activity Trading volume this week was 93.1% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -410.4% The company's stock price performance over the past 12 months beats the peer average by 96.2% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -106.1% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Allscripts Healthcare Solutions Inc (MDRX) shares closed today at 1.1% below its 52 week high of $20.77, giving the company a market cap of $2B. The stock is currently up 6.7% year-to-date, up 16.8% over the past 12 months, and up 68.0% over the past five years. This week, the Dow Jones Industrial Average fell 1.6%, and the S&P 500 fell 3.5%. Trading Activity Trading volume this week was 140.2% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 4.8% higher than its 5-day moving average, 12.6% higher than its 20-day moving average, and 26.8% higher than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -205.1% The company's stock price performance over the past 12 months beats the peer average by 84.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -106.2% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
AllScripts (MDRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Allscripts' (MDRX) revenue growth in the fourth quarter is likely to have been boosted by solid segmental performances.
Here is how AllScripts Healthcare (MDRX) and Pharvaris N.V. (PHVS) have performed compared to their sector so far this year.

Why Allscripts Stock Blasted 16% Higher Today

11:45pm, Tuesday, 25'th Jan 2022 The Motley Fool
If the company''s latest set of preliminary results is any indication, it had a far better than expected Q4 and full-year 2021.

Why Allscripts Stock Blasted 16% Higher Today

06:45pm, Tuesday, 25'th Jan 2022
If the company's latest set of preliminary results is any indication, it had a far better than expected Q4 and full-year 2021.
The stock price of Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) increased by over 14% during intraday trading today. This is why it happened.
Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) expects Q4 revenue of $390 million - $395 million, better than the consensus of $$386.75 million. For FY21, the Company expects GAAP operating inco
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE